Payment of the benefit. will at all times be subject to production of information and evidence satisfactory to us. This may include: i) evidence through examination(s) of the assured by a medical examiner appointed by us; ii) evidence by means of a blood test or other recognised process that, in the event of a claim in respect of lymphoma or ▇▇▇▇▇▇’s sarcoma, the assured is not carrying a human immunodeficiency type virus or antibodies to such a virus; iii) any other medical investigation considered appropriate by our Chief Medical Officer, and iv) sight of the assured’s medical records.
Appears in 2 contracts
Sources: Critical Illness Insurance, Critical Illness Insurance